Search Press releases Keywords From To 25 Jul 2018 UCB Half Year Report 2018: UCB continues its growth path Read More 24 Jul 2018 Transparency notifications BlackRock, Inc. Read More 12 Jul 2018 UCB and Amgen Resubmit Biologics Licence Application (BLA) for EVENITYTM (Romosozumab) to the U.S. FDA Read More 12 Jul 2018 Transparency notification Read More 6 Jul 2018 Transparency notifications BlackRock, Inc. Read More 2 Jul 2018 UCB announces approval of NEUPRO® in China to treat Parkinson’s Disease Read More Pagination First page Previous page Previous … Page 68 Page 69 Page 70 Page 71 Current page 72 Page 73 Page 74 Page 75 Page 76 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
